Monthly measles and rubella monitoring report, May 2018

Surveillance report
Publication series: Monthly measles and rubella monitoring report
Time period covered: 1 April 2017 to 31 March 2018
Cite:

 European Centre for Disease Prevention and Control. Monthly measles and rubella monitoring report, May 2018. Stockholm: ECDC; 2018

ECDC reports monthly on measles and rubella surveillance data submitted by 30 EU/EEA countries to the European Surveillance System (TESSy). This report is based on surveillance data reported to TESSy from 1 April 2017 to 31 March 2018. ECDC also monitors European measles outbreaks through epidemic intelligence and publishes the most recent updates monthly in the Communicable Disease Threats Report (CDTR).

Measles cases increase in the EU/EEA in April – significant outbreaks ongoing

Measles cases continue to increase in a number of EU/EEA countries according to the most recent measles data collected by ECDC through epidemic intelligence and published in the Communicable Diseases Threats Report (CDTR) today.

The highest number of cases to date in 2018 were in Romania (2 712), France (2 173), Greece (1 948) and Italy (805) respectively. Twenty two deaths have also been reported by these countries in 2018. Additionally, there is an ongoing outbreak in England, UK with 440 confirmed measles cases reported this year. Most of the cases have been in individuals over 15 years, highlighting the need for young adults who may have missed vaccination to check their vaccination status and get vaccinated.

ECDC also publishes its ECDC’s monthly measles and rubella monitoring report which gives more information on age and distribution of cases as well as vaccination coverage rates.

In order to reach elimination and protect those most vulnerable to severe complications and death from measles such as infants, 95% of the population needs to be vaccinated with two doses of measles-containing vaccine. Only five EU/EEA countries reported at least 95% vaccination coverage for both doses of measles-containing vaccine according to the most recent data collected (WHO 2016 ), showing that further sustained action is needed.

Publication data